Fulltext

Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials

Huttner, Angela ; Verhaegh, Els M. ; Harbarth, Stephan ; Muller, Anouk E. ; Theuretzbacher, Ursula ; Mouton, Johan W.

In: Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 9, p. 2456-2464

Ajouter à la liste personnelle
    Titre
    • Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
    Auteur
    • Huttner, Angela. Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland
    • Verhaegh, Els M.. Laboratory of Medical Microbiology and Immunology, St Elisabeth Hospital, Tilburg, The Netherlands
    • Harbarth, Stephan. Infection Control Program, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland
    • Muller, Anouk E.. Department of Medical Microbiology, Medical Centre Haaglanden, The Hague, The Netherlands
    • Theuretzbacher, Ursula. Center for Anti-infective Agents, Eckpergasse 13, Vienna, Austria
    • Mouton, Johan W.. Department of Medical Microbiology, Radboudumc, Nijmegen, The Netherlands
    Type de document
    • Postprint
    Langue
    • Anglais
    Publié dans
    • Journal of Antimicrobial Chemotherapy, 2015, vol. 70, no. 9, p. 2456-2464. Oxford University Press
    Autre version électronique
    Identifiant OAI-PMH
    • oai:doc.rero.ch:297356
    Summary
    The available evidence supports first-line treatment of lower urinary tract infections with nitrofurantoin as clinical efficacy is similar to that seen for trimethoprim/sulfamethoxazole, ciprofloxacin and amoxicillin, rates of microbiological cure are good, short- term toxicity is generally mild and acquired resistance is still relatively rare